Provided by Tiger Trade Technology Pte. Ltd.

Theriva Biologics

0.1853
+0.01025.83%
Volume:3.01M
Turnover:562.02K
Market Cap:6.25M
PE:-0.02
High:0.1949
Open:0.1785
Low:0.1752
Close:0.1751
52wk High:2.08
52wk Low:0.1651
Shares:33.74M
Float Shares:33.73M
Volume Ratio:1.24
T/O Rate:8.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.7644
EPS(LYR):-19.0286
ROE:-166.96%
ROA:-29.21%
PB:0.93
PE(LYR):-0.01

Loading ...

Theriva Biologics Seeks Shareholder Approval for Issuance of 16.2 Million Shares Under Warrant Agreement

Reuters
·
Dec 16

Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year

TIPRANKS
·
Nov 12

Theriva Biologics Q3 EPS $(0.45) Beats $(1.13) Estimate

Benzinga
·
Nov 12

Theriva Biologics reports third quarter loss and lower R&D expenses

Reuters
·
Nov 12

Theriva Biologics Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
Nov 01

Theriva Biologics: No Material Development to Account for Stock Activity

Dow Jones
·
Oct 25

Theriva Biologics sees no material development to account for unusual trading

TIPRANKS
·
Oct 25

Theriva Biologics Provides Response to Unusual Market Action

GlobeNewswire
·
Oct 25

Theriva Biologics Presents Promising Phase 2b Trial Data

TIPRANKS
·
Oct 21

Theriva Biologics Secures $4M Through Warrant Agreement

TIPRANKS
·
Oct 18

Theriva Biologics Raises $4 Million Through Warrant Inducement Private Placement

Reuters
·
Oct 18

Theriva Biologics announces warrant inducement transaction for $4M in proceeds

TIPRANKS
·
Oct 16

Theriva Biologics Announces New Preclinical Data and Next-Generation Oncolytic Adenovirus VCN-12 at ESGCT Congress, Highlighting Advances in Cancer Treatment

Reuters
·
Oct 06

Theriva Biologics Restructures, Cuts Workforce by 32%

TIPRANKS
·
Oct 03

BRIEF-Theriva Biologics Implements 32% Workforce Reduction - SEC Filing

Reuters
·
Oct 03

Theriva Biologics Inc: Expects Will Extend Its Cash Runway Into Q2 of 2026

THOMSON REUTERS
·
Oct 03

Theriva Biologics Announces Corporate Reorganization, Cuts Workforce by 32% to Focus on Clinical Trials and Licensing Activities

Reuters
·
Oct 03

Theriva Biologics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Sep 05

Theriva Biologics Q2 EPS $(1.93) Misses $(1.08) Estimate

Benzinga
·
Aug 11

Theriva Biologics Inc: Q2 EPS $-1.93

THOMSON REUTERS
·
Aug 11